Washington, DC 20006-5349
HELPLINE
With the conclusion of its latest funding cycle, the Mesothelioma Applied Research Foundation has reached the milestone of $10 million in grant funding awarded to…
It was recently announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) designated nintedanib, an oral triple angiokinase inhibitor by Boehringer Ingelheim,…
UPDATE: Aduro Biotech announced on December 12 that they have decided to discontinue its CRS-207 clinical trial and wind down each of its trials in mesothelioma.…
The World Conference on Lung Cancer is a prestigious annual event organized by the International Association for the Study of Lung Cancer (IASLC). The conference,…
Anyone who has ever done any DIY-style home renovations and construction on a home built before the 80s may be at risk for mesothelioma. Mesothelioma…
The National Comprehensive Cancer Network® (NCCN®) recently updated their treatment guidelines for malignant pleural mesothelioma. The NCCN, a not-for-profit alliance of 27 leading cancer centers devoted…
“I spent 20 years trying to do immunotherapy and we weren’t as successful as we wanted to be probably because we didn’t recognize the degree…
In a statement released on Sunday, Bayer announced that Anetumab ravtansine, its antibody-drug conjugate (ADC) tested in mesothelioma, has missed its primary endpoint failing to…
Joseph R. Testa, PhD, of the Fox Chase Cancer Center has edited a newly published book titled “Asbestos and Mesothelioma” to serve as a resource…
In 2015, data was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting from a Phase III French study that demonstrated improved survival…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
